Abstract
Background: Methamphetamine use is common among some populations of gay, bisexual and other men who have sex with men (gbMSM). This study reviewed the status of research on the efficacy of interventions that address harms among gbMSM who use methamphetamine. Methods: We searched MEDLINE, PsycINFO, CINAHL, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Google Scholar to identify publications from inception to October 23, 2017, that assessed an intervention addressing methamphetamine use among gbMSM. Results: Of 1896 potential studies and 935 unique articles screened for inclusion, 28 eligible studies assessed 26 different interventions in the following categories: pharmacological (n = 5); psychosocial (n = 20); harm reduction (n = 1). Given that outcome variables were measured in highly variable ways, we were unable to conduct a meta-analysis of intervention effects. However, 22 studies reported a statistically significant effect on one or more methamphetamine-related outcomes. Among 21 studies that included measures of sexual health-related outcomes, 18 reported a significant effect on one or more sexual health-related outcomes, and 15 of those reported a concurrent effect on both drug- and sexual health-related outcomes. Conclusions: This is the first review to provide compelling evidence that integrating interventions to address both drug- and sexual-related harms for gbMSM who use methamphetamine can be efficacious. Future research should focus on identifying differential effects of various intervention approaches by social positioning, as well as prioritize future evaluations of integrated harm reduction interventions (e.g., the distribution of harm reduction kits within sexual health care settings).
Original language | English |
---|---|
Pages (from-to) | 410-429 |
Number of pages | 20 |
Journal | Drug and Alcohol Dependence |
Volume | 194 |
DOIs | |
Publication status | Published - Jan 1 2019 |
Externally published | Yes |
Bibliographical note
Funding Information:Drs. Knight and Fast are supported by a Michael Smith Foundation for Health Research Scholar Awards. This research was funded by the Canadian Institutes of Health Research (funding reference number PCS-152596, PJT-148818 & CTW-155550). This research was also undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports Dr. Evan Wood. Dr. Nadia Fairbairn is supported by a MSFHR/St. Paul’s Hospital Foundation Scholar Award. Mohammad Karamouzian is supported by the Vanier Canada Graduate and Pierre Elliot Trudeau Doctoral Scholarships. The above funding sources had no involvement in the planning, preparation, and submission of the review paper.
Publisher Copyright:
© 2018
ASJC Scopus Subject Areas
- Toxicology
- Pharmacology
- Psychiatry and Mental health
- Pharmacology (medical)